Beyond the Retina: Leveraging SD-OCT Biomarkers to Uncover Systemic Cardiovascular & Neurodegenerative Disease

Beyond the Retina: Leveraging SD-OCT Biomarkers to Uncover Systemic Cardiovascular & Neurodegenerative Disease

As retina specialists, our primary focus has traditionally been the diagnosis and management of ocular pathology. However, the rapidly advancing resolution and speed of Optical Coherence Tomography (SD-OCT) and OCT Angiography (OCTA) have transformed the retina into a clear, noninvasive window through which we can evaluate systemic microvascular and neural health.Recent insights highlight how subtle, subclinical retinal ischemic signatures can serve as early biomarkers for cardiovascular events and neurodegenerative conditions—long before catastrophic clinical events occur.


Key Highlights for Clinical Practice

1. Retinal Ischemia & The Middle Retina

  • Paracentral Acute Middle Maculopathy (PAMM): Manifesting as a hyperreflective band involving the inner nuclear layer (INL) on SD-OCT, PAMM indicates acute middle retinal ischemia localized to the deep capillary plexus (DCP).
  • Retinal Ischemic Perivascular Lesions (RIPLs): Chronic or resolving focal ischemic insults in the INL lead to focal INL atrophy and a compensatory upward expansion of the outer nuclear layer. These lesions—termed RIPLs—are persistent SD-OCT biomarkers of past subclinical ischemic events.

2. The Cardiovascular Connection (RIPLs as Biomarkers)

Oculomics & Cardiovascular Risk

Retinal Ischemic Perivascular Lesions (RIPLs) — Cardiovascular Biomarker

Increased Cardiovascular Disease Odds

Detection of even a single RIPL on SD-OCT serves as an independent marker of systemic vascular risk:

Odds Ratio (OR): 2.34 (95% CI: 1.16–4.74)

More than double the odds of coexisting cardiovascular disease, independent of age, sex, and smoking status.

Correlation with 10-Year ASCVD Risk

The presence and lesion count of RIPLs directly correlate with validated cardiometabolic scoring algorithms:

ACC / AHA Risk Stratification: Strongly associated with intermediate and high 10-year ASCVD scores

Clinical Pearl: Oculomics in Routine Practice

RIPLs represent subclinical, localized focal ischemic infarcts of the middle retinal layers. Incidental identification on macular SD-OCT B-scans provides a critical screening opportunity to prompt cardiovascular risk evaluation and preventive medical management.

3. Neurodegenerative Disease Biomarkers

  • Alzheimer’s Disease (AD): OCTA scans reveal reduced superficial and deep capillary plexus perfusion density in clinical and preclinical AD patients.
  • Parkinson’s Disease (PD): Inner retinal layer thinning on SD-OCT strongly correlates with PD progression.
  • Multiple Sclerosis (MS): Reduced optic nerve head flow index on OCTA offers potential diagnostic utility.

4. The Future: AI & Deep Learning Predictive Models

  • Deep learning algorithms applied to retinal photographs and structural scans can predict myocardial infarction with 74% sensitivity and 71% specificity using minimal clinical baseline information.
  • Lower retinal microvascular density and altered vascular branching complexity significantly correlate with higher overall cardiometabolic disease risk and all-cause mortality.

Takeaways for Retina Specialists

Incorporating careful inspection of the INL and deep capillary plexus for RIPLs during routine SD-OCT reviews provides actionable clinical value. Identifying these subclinical markers allows retina specialists to collaborate proactively with primary care physicians and cardiologists, establishing early interventions for high-risk patients.


Estawro R, Voichanski S, Sarraf D. Coincident PAMM and AMN: Finding the missing link. Retina Today. 2023;18(6):52–54.